financetom
Business
financetom
/
Business
/
LendingTree Seen Benefiting From Insurance Rebound, Lower Interest Rates, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LendingTree Seen Benefiting From Insurance Rebound, Lower Interest Rates, Oppenheimer Says
Jul 30, 2024 11:18 AM

01:45 PM EDT, 07/30/2024 (MT Newswires) -- LendingTree's ( TREE ) is seen benefiting from accelerating insurance growth with site conversion initiatives and lower interest rates bolstering the consumer and home segments, Oppenheimer said Monday in a report.

The insurance "upcycle has legs" amid strong home demand and premium rate increases in large states such as California, while LendingTree's ( TREE ) management plans to increase its sales team to drive higher conversion rates, the report said.

Oppenheimer boosted its Q3 revenue forecast to $245 million from $184 million with Q4 projected at $227 million, up from $168 million, after Lending Tree increased 2024 guidance 21%.

The firm increased its 2025 revenue outlook to $939 million from $802 million.

Oppenheimer raised its price target on Lending Tree stock $65 from $55 and kept its outperform rating.

Lending Tree shares fell 0.3% in recent trading Tuesday.

Price: 52.37, Change: -0.13, Percent Change: -0.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Solventum Faces Activist Shareholder Pressure to Improve Performance
Solventum Faces Activist Shareholder Pressure to Improve Performance
Jan 8, 2025
01:27 PM EST, 01/08/2025 (MT Newswires) -- Solventum's ( SOLV ) largest shareholder Trian Fund Management said Wednesday that the company's separation from 3M (MMM) should have enable significant improvements, but is not living up to the potential. Solventum ( SOLV ) performance has declined since the spinoff and is barely growing at low-20% operating margin despite a favorable core...
Why Is Accolade Stock Trading Over 100% On Tuesday?
Why Is Accolade Stock Trading Over 100% On Tuesday?
Jan 8, 2025
Transcarent agreed to buy Accolade Inc Wednesday for $621 million. The purchase price works out to $7.03 per share in cash. Accolade is a Personalized Healthcare company that offers employer, health plan, and consumer solutions combined with virtual primary care and mental health, medical opinion, and care navigation. The transaction is expected to bring Transcarent’s generative AI-powered WayFinding and comprehensive care experiences —...
Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing
Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing
Jan 8, 2025
01:37 PM EST, 01/08/2025 (MT Newswires) -- Stephen Lovass, Executive Vice President, on January 06, 2025, sold 1,299 shares in Nordson ( NDSN ) for $268,620. Following the Form 4 filing with the SEC, Lovass has control over a total of 7,546 shares of the company, with 7,347 shares held directly and 199 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/72331/000007233125000012/xslF345X05/wk-form4_1736361253.xml Price: 203.84,...
Why CureVac (CVAC) Stock Is Moving
Why CureVac (CVAC) Stock Is Moving
Jan 8, 2025
Shares of CureVac BV fell by 12.3% to $4.10 Wednesday afternoon. The pullback could be due to profit-taking after Tuesday's strong gains, which were fueled by heightened concerns over respiratory illnesses across the U.S. The surge in healthcare visits, driven by higher cases of seasonal influenza, COVID-19 and RSV, has renewed interest in vaccine and therapeutic manufacturers this week. Read...
Copyright 2023-2026 - www.financetom.com All Rights Reserved